UK biotechnology firm completes £35.5m fundraising

Oxford Biomedica, a UK biotechnology company, has raised £35.5m (€57.8m) in the equity market just a week after other biotech firms postponed or significantly scaled back their offers.

NM Rothschild, the investment bank, and Beeson Gregory, the UK broker, underwrote Oxford's placing and open offer with UK and European investors of 64.5 million shares at 55p each.

WSJ Logo
JPMorgan to Pay $330 Million Over 1MDB TransactionsExternal link

JPMorgan to Pay $330 Million Over 1MDB Transactions